Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(11%)
Results Posted
100%(7 trials)
Terminated
1(11%)

Phase Distribution

Ph early_phase_1
1
11%
Ph phase_4
3
33%
Ph not_applicable
5
56%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 43 (33.3%)
N/A5 (55.6%)

Trials by Status

completed778%
recruiting111%
terminated111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_4

Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT

NCT05655754
completednot_applicable

Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs

NCT02624050
completedearly_phase_1

EEG Characteristics in ECT

NCT04022226
completedphase_4

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

NCT04187196
completedphase_4

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

NCT01881763
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05655754Phase 4

Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT

Recruiting
NCT02624050Not Applicable

Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs

Completed
NCT04022226Early Phase 1

EEG Characteristics in ECT

Completed
NCT04187196Phase 4

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

Completed
NCT01881763Phase 4

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

Completed
NCT02752724Not Applicable

Ketamine Anesthesia for Improvement of Depression in ECT

Completed
NCT01567852Not Applicable

Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time

Completed
NCT01309581Not Applicable

Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

Terminated
NCT01367119Not Applicable

Ketamine Anesthesia in Electroconvulsive Therapy

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9